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http://dx.doi.org/10.1016/j.jaci.2014.10.046prospective cohort study. Current asthma at 8, 14, and 17 years
of age was based on questionnaires. Lung function and
bronchial responsiveness or reversibility were measured during
clinic visits at 8 and 15 years of age.
Results: Rapid weight growth between 0 and 3months of age was
most consistently associated with increased risks of current
asthma at the ages of 8 and 17 years, bronchial responsiveness at
age 8 years, and bronchial reversibility at age 15 years. Rapid
weight growth was associated with lung function values, with the
strongest associations forweight gain between 3 and 7 years of age
and higher forced vital capacity (FVC) and FEV1 values at age 15
years (0.12 [95%CI, 0.08 to 0.17] and 0.11 [95%CI, 0.07 to 0.15],
z score per SD, respectively) and weight growth between 0 and 3
months of age and lower FEV1/FVC ratios at age 8 and 15 years
(20.13 [95% CI, 20.16 to20.10] and20.04 [95% CI, 20.07 to
20.01], z score per SD, respectively). Rapid length growth was
associated with lower FVC and FVC1 values at age 15 years.
Conclusion: Fasterweight growth in early childhood is associated
with asthma and bronchial hyperresponsiveness, and faster
weight growth across childhood is associated with higher FVC
and FEV1 values. (J Allergy Clin Immunol 2015;135:1435-43.)
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Asthma is the most prevalent chronic respiratory disease in
children worldwide.1,2 Many factors have been associated with
increased risk of asthma or lower lung function, such as
gestational age, tobacco smoke exposure, breast-feeding habits,
and a family history of asthma or allergy.3-7 Respiratory
morbidity might also be the result of abnormal growth. Fetal
growth8-10 and low birth weight10-16 have been associated with
asthma. Several studies have explored the associations of infant
or childhood growth with the risk of asthma or lung function in
later life.10,17-26 They reported an increased risk of asthma
symptoms in preschool children with accelerated growth in early
infancy,10,23 an increased incidence of asthma at 6 years after a
rapid increase in body mass index in early childhood,22 a lower
FEV0.4 value in the first months of life in children with greater
postnatal weight gain,21 and a negative association of growth
with lung function during the first year of life.27 However, other
studies observed no evidence for increased risk of asthma caused
by rapid growth24 or observed that weight gain during the first
year was positively associated with lung function.19 These
inconsistencies could be explained in part by methodological
issues, including differences in the definitions of growth or
asthma outcomes and adjustment for potential confounders.
It was suggested in a published study that growth in early
infancy, especially from birth to 3 months,10 might be an1435
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whether this association persists until adolescence or influences
lung function, although tracking of lung function suggests that its
trajectory is established bymidchildhood.20,28 It is also not known
whether the first 3 months after birth is the only important time
period or whether any specific period after the first year of age
might play a role as well.
The underlying mechanism of the associations between growth
and respiratory morbidity might include abnormal growth and
development of the lungs or immunologic or inflammatory
effects, such as adiposity-related systemic and tissue-specific
inflammation.29-33 To test our hypothesis that rapid early growth
is negatively associated with respiratory health, we examined the
association of children’s growth trajectories from birth until age
10 years with current asthma, bronchial responsiveness or
reversibility, and lung function in adolescence in a population-
based prospective birth cohort study among 9723 children.METHODS
Design and setting
Subjects were participants in the Avon Longitudinal Study of Parents and
Children (ALSPAC) in the United Kingdom, which has been described
previously34 and on the study’s Web site (www.bristol.ac.uk/alspac). In brief,
15,247 pregnant women residing in one of 3 Bristol-based health districts with
an expected delivery date of between April 1, 1991, and December 31, 1992,
were recruited and gave birth to 14,316 singleton children who were alive at
the age of 1 year. Children with no information on either growth trajectories
(n5 701) or any asthma outcome (n5 3,892) were excluded, leaving a total
of 9,723 children included in the current analyses (see Fig E1 in this article’s
Online Repository at www.jacionline.org). Ethical approval for the study was
obtained from the ALSPAC Law and Ethics Committee and local research
ethics committees. Witten informed consent was obtained from all
participants and their parents or guardians.Growth trajectories
Height and weight measurements were available from birth up to age 10
years from a variety of sources (see the Methods section and Table E1 in this
article’s OnlineRepository atwww.jacionline.org for full details). Linear spline
multilevel models were used to estimate trajectories of height and weight. The
models estimate mean and person-specific birth weight or length andmean and
person-specific rates of weight or height growth between 0 and 3 months, 3
months and 1 year, 1 and 3 years, 3 and 7 years, and 7 and 10 years of age
and are described in full elsewhere.35 Early growth was defined as growth be-
tween birth and the age of 1 year, midchildhood growth as growth between
the ages of 1 and 7 years, and late childhood growth as growth between 7 and
10 years of age. We generated SD scores (z scores) for birth weight and length
and rate of weight/height growth in each period of childhood by subtracting the
mean from the person-specific value and dividing by the SD. These SD scores
for birthweight/length and rates of growth are used as exposures in our analyses.Asthma and lung function
Current asthma status was obtained at the ages of 8, 14, and 17 years.
Current asthma was defined as a reported doctor’s diagnosis of asthma everand reportedwheezing, asthma, or use of asthmamedication in the previous 12
months. Skin prick test reactivity was determined at the age of 7 years. A child
was deemed to react to an allergen (grass, house dust, or cat) if their wheal
and/or flare responses were 2 mm or greater and they had no reaction to the
negative control. Bronchial hyperresponsiveness, unselected for asthma or
wheezing, was measured at the ages of 8 and 15 years.36 At age 8 years, we
tested the provoking dose of methacholine causing a decrease in FEV1 from
baseline. The dose-response slope was calculated by fitting a linear function
to the plot of percentage decrease from baseline. We dichotomized bronchial
responsiveness using the highest tertile as responders and the rest as
nonresponders. At age 15 years, we defined bronchial reversibility as a change
of equal to or greater than 12% between FEV1 before and after inhalation of a
standard dose (400 mg) of salbutamol.37 Spirometry (Vitalograph 2120;
Vitalograph, Maids Moreton, United Kingdom) was performed at 8 and
15 years of age according to American Thoracic Society standards.38 Lung
function measurements (FEV1, forced vital capacity [FVC], forced expiratory
flow between 25% and 75% [FEF25-75], FEV1/FVC ratio, and FEF25-75/FVC
ratio) were converted into sex-, age-, and height-adjusted z scores (see
Table E1 for time points of outcomes).39
Covariates
Maternal age, highest qualification, body mass index, parity, and a history
of asthma or atopy were reported in questionnaires at 12 weeks of gestation,
and smoking during pregnancy was assessed at 18 weeks of gestation by using
self-completion questionnaires sent to the mothers. Maternal anxiety during
pregnancy was measured at 32 weeks of pregnancy and was defined as the
highest quartile of the Crown-Crisp Experiential Index.40 Children’s gesta-
tional age and sex were obtained from birth records. Breast-feeding status at
age 8 months was obtained from maternal self-completion questionnaires.
Statistical analysis
We used logistic regression models to assess associations between growth
trajectories and current asthma, atopy, and bronchial responsiveness or
reversibility. Linear regression models were used to assess associations of growth
trajectorieswith lung functionmeasurements.Analyseswereadjusted forpotential
confounders, includingmaternal age, bodymass index, anxiety, education, history
of asthma or atopy, smoking habits, parity, and the child’s sex, gestational age at
birth, and breast-feeding status. Models of weight gain were additionally adjusted
for birth weight, and preceding rates of height-adjusted weight growth trajectories
andmodels of height gain were additionally adjusted for preceding rates of height
growth trajectories and birth weight. Models for current asthma or lung function
were additionally adjusted for previous current asthma or lung function
measurements. In addition, body mass index at the age of outcome assessment
was added as an interaction to explore potential effect modification on the
associations of childhood growth with asthma and lung function.
Missing data in confounders were imputed by using multiple imputations.
Percentages of missing values within the population for analysis were lower
than or near 10%, except for maternal body mass index (13.1%), anxiety
(13.6%), and child’s breast-feeding duration (11.5%). Ten new data sets were
created by means of imputation based on all covariates, determinants, and
outcomes in the model.41 All data sets were analyzed separately, after which
results were combined. No differences in results were observed between
analyses with imputed missing data or complete cases only. Therefore we
present only results based on imputed data sets. Statistical analyses were
performed with the Statistical Package of Social Sciences version 19.0 for
Windows (SPSS, Chicago, Ill).RESULTS
Characteristics of mothers and their children are presented in
Table I. Children were born at a median gestational age of 40
weeks (95% range, 35-42 weeks), with an average birth weight
of 3436 grams (SD, 524 grams). Current asthma was reported
in 13.9%, 13.2%, and 15.3% of the children at the age of 8, 14,
and 17 years. All covariates differed between those included
TABLE I. Characteristics of mothers and their children (n 5
9723)
Maternal characteristics Observed Imputed
Age (y)
<20 4.3 (404) 4.3 (417)
20-24 19.8 (1873) 19.8 (1928)
25-29 41.8 (3945) 41.8 (4066)
30-34 26.1 (2466) 26.1 (2537)
>_35 8.0 (756) 8.0 (776)
Missing 2.9 (279) —
Body mass index (kg/m2)
<20 18.2 (1541) 18.7 (1815)
20-24 61.3 (5183) 59.5 (5793)
25-29 15.2 (1282) 16.7 (1623)
>_30 5.3 (448) 5.1 (492)
Missing 13.1 (1,269) —
Education (%)
Low/medium 60.3 (5454) 60.7 (5902)
Higher 39.7 (3596) 39.3 (3821)
Missing 6.9 (673) —
History of asthma (%)
No 88.8 (8042) 88.7 (8629)
Yes 11.2 (1018) 11.3 (1094)
Missing 6.8 (663) —
Anxiety during pregnancy (%)
No 73.3 (6162) 73.3 (7126)
Yes 26.7 (2241) 26.7 (2597)
Missing 13.6 (1220) —
Smoking during pregnancy (%)
No 84.0 (7753) 83.9 (8159)
Yes 16.0 (1472) 16.1 (1564)
Missing 5.1 (498) —
Parity (%)
0 46.0 (4181) 46.1 (4486)
>_1 54.0 (4909) 53.9 (5237)
Missing 6.5 (633) —
Child characteristics
Female sex (%) 49.5 (4814) 49.5 (4814)
Gestational age at birth (wk) 40.0 (35.0-42.0) 40.0 (35.0-42.0)
Birth weight (g) 3438 (532) 3436 (524)
Breast-feeding duration (%)
Never 23.3 (1999) 23.7 (2308)
<3 mo 22.9 (1972) 23.0 (2236)
3-6 mo 17.1 (1472) 17.1 (1664)
>_6 mo 36.8 (3163) 36.2 (3515)
Missing 11.5 (1117) —
Values are means (SDs), medians (2.5th-97.5th percentiles), or percentages (absolute
numbers).
Gestational age at birth was missing for 2.9% (n5 279), and birth weight was missing
for 3.9% (n 5 378).
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of asthma (see Table E2 in this article’s Online Repository at
www.jacionline.org).Childhood growth with asthma
We observed no evidence of an association between higher
birth length or weight and current asthma (Table II). Height
growth in midchildhood tended to be negatively associated with
current asthma at age 8 years, with the strongest evidence of
association for height gain between 3 and 7 years of age and
asthma at 8 years of age (odds ratio [OR], 0.75 [95% CI,
0.66-0.86] per SD increase). More rapid weight gain during early
childhood tended to be positively associated with current asthma,with the most consistent associations observed for weight gain
between 0 and 3 months of age and asthma at 8 and 17 years of
age (OR, 1.10 [95% CI, 1.02-1.19] and 1.18 [95% CI,
1.01-1.37], respectively; Table II). We did not find strong
evidence that current body mass index modified the association
of childhood growth with asthma. P values for the cross-
product of growth measurements with body mass index were
greater than .05. No associations were observed between any
growth measures and skin prick test reactivity (see Table E3 in
this article’s Online Repository at www.jacionline.org).Childhood growth with bronchial responsiveness
We observed no evidence of an association between higher
birth length or weight and bronchial hyperresponsiveness
(Table III). Also, no evidence was found for associations between
height gain in early childhood, midchildhood, or late childhood
and bronchial responsiveness or reversibility at 8 and 15 years
of age, respectively. Higher weight gain in early childhood
(between 0 and 3 and 3 and 12months of age only) was associated
with an increased risk of bronchial responsiveness to methacho-
line at 8 years (OR, 1.11 [95% CI, 1.03-1.20] and 1.09 [95%
CI, 1.00-1.19], respectively, per SD increase) and bronchial
responsiveness to salbutamol at 15 years (OR, 1.14 [95% CI,
1.00-1.31] and 1.24 [95% CI, 1.07-1.42], respectively, per SD
increase). No strong evidence was observed for effect
modification of childhood growth with current body mass
index on bronchial responsiveness or reversibility (P for
interaction > .05).Childhood growth with lung function
Fig 1 and Table E4 in this article’s Online Repository at
www.jacionline.org show the associations of height and weight
trajectories with lung function measurements at 8 and 15 years
of age. Higher birth length was associated with a lower FVC
and FEV1 z score at age 15 years (20.14 [95% CI, 20.19 to
20.09] and 20.12 [95% CI, 20.17 to 20.08] per SD increase,
respectively; Fig 1, A and C). Higher birth length was also
associated with higher FEV1/FVC and FEF25-75/FVC ratios
(0.05 [95% CI, 0.00-0.10] and 0.06 [95% CI, 0.02-0.11] per SD
increase, respectively; Fig 1, G and I). After birth, more rapid
height gain in early childhood and midchildhood was most
consistently associated with a lower FVC and FEV1 values at
age 15 years but not with other lung function variables or ratios
or with lung function at age 8 years (Fig 1, A-I).
Higher birth weight was most strongly associated with higher
FVC, FEV1, and FEF25-75 z scores at age 8 years (0.08 [95% CI,
0.04-0.12], 0.08 [95% CI, 0.04-0.12], and 0.05 [95% CI, 0.01-
0.09] per SD increase, respectively) and with higher FVC values
at age 15 years only (0.06 [95% CI, 0.01-0.11]; Fig 1, B, D, and
F). Also, higher birth weight was associated with reduced
FEV1/FVC and FEF25-75/FVC ratios at age 15 years (Fig 1, H
and J). After birth, more rapid weight growth throughout
childhood was associated with higher FVC and FEV1 values,
with the greatest effect estimates for weight gain in midchildhood
and FVC and FEV1 values at age 15 years (0.12 [95% CI,
0.08-0.17] and 0.11 [95% CI, 0.07-0.15], z score per SD,
respectively; Fig 1, B and D). For the other lung function
variables, more rapid weight gain in early childhood was
associated with a decreased FEF25-75 value at 8 years of age
TABLE II. Growth trajectories and current asthma
Current asthma
8 y 14 y 17 y
n 5 7794 P value n 5 5590 P value n 5 3531 P value
Height
Birth length (SD) 0.97 (0.88-1.08) .60 0.97 (0.84-1.12) .66 0.94 (0.76-1.16) .48
0-3 mo (SD/mo) 0.98 (0.91-1.06) .57 0.97 (0.87-1.09) .59 1.05 (0.89-1.24) .55
3-12 mo (SD/mo) 1.02 (0.91-1.14) .76 0.93 (0.79-1.08) .32 1.05 (0.85-1.30) .66
1-3 y (SD/mo) 0.91 (0.84-0.99) .03 0.96 (0.85-1.08) .48 0.91 (0.77-1.09) .31
3-7 y (SD/mo) 0.75 (0.66-0.86) <.001 1.10 (0.92-1.31) .32 1.14 (0.88-1.47) .32
7-10 y (SD/mo) — 1.06 (0.84-1.35) .62 0.81 (0.57-1.14) .23
Weight
Birth weight (SD) 0.99 (0.89-1.10) .81 0.97 (0.83-1.13) .69 1.13 (0.91-1.41) .27
0-3 mo (SD/mo) 1.09 (1.02-1.17) .02 0.97 (0.88-1.08) .61 1.18 (1.01-1.37) .03
3-12 mo (SD/mo) 1.10 (1.02-1.19) .02 1.10 (0.98-1.24) .10 0.89 (0.75-1.06) .18
1-3 y (SD/mo) 1.11 (1.02-1.20) .02 1.03 (0.91-1.16) .68 1.03 (0.87-1.23) .72
3-7 y (SD/mo) 1.03 (0.94-1.13) .57 0.94 (0.82-1.08) .39 1.04 (0.86-1.26) .69
7-10 y (SD/mo) — 1.00 (0.82-1.21) .97 0.92 (0.70-1.21) .54
Values are ORs (95% CIs). Models are adjusted for maternal age, education level, history of asthma, body mass index, parity, smoking during pregnancy, anxiety, and the child’s
sex, gestational age, breast-feeding duration, and previous height or weight gain. Models of weight were additionally adjusted for preceding height and weight growth trajectories,
and models of height were additionally adjusted for preceding height growth trajectories and birth weight. Also, models were additionally adjusted for previous current asthma.
TABLE III. Growth trajectories and bronchial responsiveness at age 8 years and bronchial reversibility at age 15 years
Methacholine responsive at 8 y n 5 4389 P value Salbutamol responsive at 15 y n 5 3750 P value
Height
Birth length (SD) 1.00 (0.90-1.11) .98 1.01 (0.84-1.21) .95
0-3 mo (SD/mo) 0.96 (0.89-1.04) .31 1.12 (0.97-1.29) .12
3-12 mo (SD/mo) 0.99 (0.89-1.11) .88 1.06 (0.87-1.28) .59
1-3 y (SD/mo) 1.01 (0.92-1.10) .82 1.04 (0.89-1.21) .62
3-7 y (SD/mo) 0.96 (0.84-1.10) .55 1.18 (0.95-1.48) .14
7-10 y (SD/mo) — 1.04 (0.77-1.40) .81
Weight
Birth weight (SD) 0.94 (0.84-1.06) .29 0.93 (0.76-1.14) .47
0-3 mo (SD/mo) 1.11 (1.03-1.20) .006 1.14 (1.00-1.31) .05
3-12 mo (SD/mo) 1.09 (1.00-1.19) .05 1.24 (1.07-1.42) .003
1-3 y (SD/mo) 0.95 (0.87-1.04) .23 0.87 (0.75-1.01) .08
3-7 y (SD/mo) 1.00 (0.91-1.10) .96 1.09 (0.93-1.28) .31
7-10 y (SD/mo) — 0.93 (0.74-1.17) .52
Values are ORs (95% CIs) of bronchial responsiveness or reversibility. Models are adjusted for maternal age, education level, history of asthma, body mass index, parity, smoking
during pregnancy, anxiety, and the child’s sex, gestational age, breast-feeding duration, and previous height or weight gain. Models of weight were additionally adjusted for
preceding height and weight growth trajectories, and models of height were additionally adjusted for preceding height growth trajectories and birth weight.
Methacholine responsive, Highest tertile versus lower tertiles; Salbutamol responsive, greater than 12% change in FEV1 vs less than 12% change.
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1438 SONNENSCHEIN-VAN DER VOORT ET ALonly (Fig 1, F). We observed lower FEV1/FVC and FEF25-75/FVC
ratios at the ages of 8 and 15 years for early rapid weight gain,
followed by normal ratios formidchildhoodweight gain but lower
ratios for late rapid weight gain (Fig 1, H and J). We observed
effect modification of childhood weight growth by current body
mass index on lung function (P for interaction < .05) but not of
childhood height growth (P for interaction > .05). Stratified
analyses for body mass index showed that the effect estimates
of childhood weight growth for FVC and FEV1 were larger in
the group of children with a normal body mass index compared
with the overweight children (see Table E5 in this article’s Online
Repository at www.jacionline.org).DISCUSSION
Our results suggest positive associations of rapid weight
growth during early childhood and midchildhood with current
asthma, higher weight growth during early childhood withincreased bronchial responsiveness or reversibility, and higher
weight growth in childhood with higher overall lung volumes but
increasedmeasures of obstruction (FEV1/FVC and FEF25-75/FVC
ratios) in childhood. Higher length at birth and height growth in
childhood were associated with lower lung volumes but less
consistently associated with the other respiratory outcomes.Comparison with previous studies
Previous studies of the association of childhood growth with
asthma have reported an increased risk of asthma symptoms in
preschool children with accelerated growth in early infancy.10,23
A previous study that measured asthma at an older age (6 years)
showed no evidence for increased risks caused by changes in
growth using similarly defined growth trajectories as in our study.
However, those authors did report increased risks of ever
wheezing in those with higher weight growth in early child-
hood.24 Differences in results with our study might be explained
A B
C
E F
D
FIG 1. Growth (height and weight) with lung function measures of FVC (A and B), FEV1 (C and D), FEF25-75
(E and F), and FEV1/FVC (G and H) and FEF25-75/FVC (I and J) ratios. Values are differences in z score lung
function (95% CIs). Z scores were calculated for sex, age, and height at the time of measurement. FEV1/FVC
and FEF25-75/FVC sex-adjusted z scores were additionally adjusted for age and height of measurement.
Models are adjusted for maternal age, education level, bodymass index, parity, smoking during pregnancy,
anxiety, history of asthma, and the child’s sex, gestational age, and breast-feeding duration. Models of
weight were additionally adjusted for preceding height and weight growth trajectories, and models of
height were additionally adjusted for preceding height growth trajectories and birth weight. Models for
lung function at 15 years of age were additionally adjusted for lung function measures at age 8 years.
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FIG 1. (Continued).
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term-born children only) and the age at which asthma was
measured (early childhood, midchildhood, or late childhood).
A meta-analysis on body mass index gain in early childhood
and midchildhood suggested that more rapid body mass index
gain in early childhood but not thereafter was associated with
an increased incidence of asthma at age 6 years,22 which is
consistent with our findings about asthma at age 8 years.
To the best of our knowledge, no previous studies have
examined the relationship between childhood growth and
bronchial responsiveness or reversibility. However, because
asthma is associated with bronchial hyperresponsiveness,42 the
association between early childhood weight gain and the
objective measure of bronchial responsiveness is in line with
previous studies on growth and asthma outcomes,9,10,22-24,27
and this strengthens our conclusions about the association with
asthma by using both objective and self-reported outcome
measures. Previous studies that measured lung function during
early childhood reported lower FEV0.4 values in the first months
of life in term-born children with greater postnatal weight
gain.21 Turner et al27 showed a negative association of growth
between 1 and 12 months of age and lung function change
(V9max FRC [maximal flow at functional residual capacity])
during the same period. Only a tendency toward an association
of growth with lower FEF25-75 values at 11 years of age wasobserved.27 Our findings were in line with these results. In
contrast, Canoy et al19 showed in adults that weight gain during
the first year was positively associated with adult lung function
independent of birth weight. Additionally, we showed in a large
number of subjects that weight gain in midchildhood and late
childhood was associated with lung function independent of
birth weight and weight gain in early childhood.Interpretation of results
The most prominent and novel findings in this study are
the positive associations of weight gain in early childhood,
specifically weight gain in the first 3 months of life, and lung
function changes at 8 and 15 years of age. This early postnatal
period has been observed previously to be important for the
development of asthma symptoms and decreased lung function up
to preschool age.10,21,23,24 Our results suggest that the effects of
rapid weight gain in the first 3 months of life on asthma and
bronchial hyperresponsiveness persist until adolescence. Weight
gain between 0 and 3 months of age was associated with asthma
at both 8 and 17 years of age, whereas weight gain between 3 and
12 months of age was only associated with asthma at age 8 years.
This might be due to a different underlying mechanism between
these intervals, such as early developmental influences resulting
in persistent changes in airway or immune development after
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rapid growth and multiple other exposures of influence after these
first months leads tomodifiable changes. However, this alsomight
be a chance finding or caused by the smaller number of children in
the older age group. Therefore these associations need to be
replicated in other studies. Additionally, rapid weight growth in
midchildhood and late childhood was associated with changes
in lung function variables. The underlying mechanisms of rapid
weight gain in childhood on asthma and lung function outcomes
are unclear and should be assessed in future studies. We speculate
that abnormal growth and development of the lungs, possibly with
mismatch between airway and alveolar growth or immunologic
and inflammatory effects with lung and airway remodeling, might
play a role.29,32,43 Both airways and alveoli continue to develop,
at least until adolescence.44 Therefore exposures, including
growth, during childhood are likely to influence this development.
Our results suggest that growth in the first months after birth is the
most important in the association with asthma and lung function
because most rapid developmental and growth changes occur
during this time. Growth after this early period also might
influence lung function butmight not completely reverse the early
effects. Also, higher leptin levels have been associated with lower
lung function in childhood, suggesting a possible mechanism
mediated by adiposity-related hormones that might influence
pulmonary growth factors, such as vascular endothelial growth
factor, transforming growth factor, and insulin-like growth
factor.45 Also, unmeasured factors determining early growth
might influence respiratory health in adolescence. The FEV1/
FVC ratio is a measure of obstruction, and decreased values are
a feature of asthma. We observed increases in FVC and FEV1
values in association with rapid early weight gain but a lower
FEV1/FVC ratio, which would be consistent with greater
influence of early rapid weight gain on lung volume than airway
growth. Because weight gain in infancy is proportionally greater
than in subsequent years, effects of rapid weight gain on an
imbalance between FEV and FVC values might be most
influenced during this specific period. The FEF25-75/FVC ratio
has also been suggested as a measure of dysanapsis in which
airways are small in relation to total lung capacity,46 and
therefore our finding of rapid weight gain associations with lower
FEF25-75/FVC ratios would be consistent with this explanation.
The associations of early childhood and midchildhood height
growth and decreased FVC and FEV1 values at the age of 15 years
could also point to dysanapsis; however, we did not observe an
association of height growth with the FEV1/FVC ratio. Therefore
height growth is less likely to be associated with a mismatch
between airway and alveolar growth.
Althoughwe did not observe an association of growth with skin
prick test reactivity, another possible explanation for effects of
rapid weight gain on lung function is through influence of
adipose tissue on the developing immune system through
secretion of immunologically active factors, including adipokines
and chemokines, which stimulate release of TNF-a and
interleukins.47 In mice leptin has been shown to enhance airway
responsiveness, suggesting an immunomodulatory role,48 and
the effect has also been reported in human subjects, although re-
sults are inconsistent.49-51 If this potential underlying mechanism
is a factor in the association between growth and asthma, we
suggest that not only obesity but also weight gain in normal and
overweight children leads to increased leptin levels. We observed
no evidence that body mass index modified associations ofchildhood growth with asthma and bronchial responsiveness or
reversibility or on the association of childhood height growth
with lung function. We observed effect modification of childhood
weight growth by current bodymass index on lung function (P for
interaction < .05). Stratified analyses for body mass index showed
that the effect estimates of childhood weight growth for FVC
and FEV1 values were larger in the group of children with a
normal body mass index compared with overweight children
(see Table E2). This suggests that the development of lung and
airway volumes of overweight subjects are less influenced by
weight gain in childhood than lung and airway volumes of
normal-weight children. The underlying mechanisms should be
studied in future research. Finally, a common unknown factor
that increases weight gain and is also responsible for a higher
risk of respiratory morbidity, such as shared genetic risk, might
be involved.52Strengths and limitations
This study was embedded in a population-based prospective
cohort study, with a large number of subjects being studied from
pregnancy onward and detailed and prospectively acquired
information about growth and respiratory morbidity. Modeled
growth trajectories for this population enabled us to take account
of different timings and numbers of measurements between
children. Additionally, previous changes in weight and height
were considered in the models, and therefore changes in the time
intervals reflect growth during that specific interval independent
of earlier growth and not simply catch-up or down growth after
early aberrant growth. Because puberty can influence pulmonary
physiology, an important limitation of our growth models is that
they do not continue during puberty. Growth and puberty have a
bidirectional relationship, which makes disentangling their
effects complex. Further research is needed to explore the effects
of growth during and after puberty with respiratory health. Lung
function measurements were made by using the same methods at
2 time points, and methacholine challenge or bronchodilator
reversibility were used to evaluate bronchial responsiveness,
producing objective respiratory outcomes. After Bonferroni
corrections for multiple testing (P <.00625), only the associations
of growth with asthma did not hold. However, statistical
corrections for multiple comparisons seem conservative because
all exposures and outcomes are correlated.We adjusted for a large
number of confounders.
Loss to follow-up data in the ALSPAC cohort is associated with
social deprivation but not with atopic predisposition.53
Nonresponse and loss to follow-up would lead to biased effect
estimates if associations of childhood growth with respiratory
outcomes differed between those included and not included
in the analyses. This is unlikely but difficult to study. Therefore
we believe that the differences in covariates between
those included and excluded did not influence the effect estimates
but might have affected the generalizability of the observed
effects.
Also, wewere unable to take fetal growth into account. Growth
in childhood might be the result of various fetal growth patterns
that could underlie associations of growth in childhood with
asthma and lung function. However, previous studies showed
inconsistent effects of fetal growth with respiratory outcomes.8,10
In conclusion, our results suggest that rapid weight growth
during specific intervals in childhood is associated with current
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1442 SONNENSCHEIN-VAN DER VOORT ET ALasthma, increased bronchial responsiveness and reversibility, and
higher lung volumes and measures of obstruction. Rapid length
growth was only associated with lower overall lung volume.
Therefore changes in weight, especially early weight growth,
appear to be important in lung development. Further studies are
needed to replicate these findings and to explore the underlying
mechanisms of the effect of growth in specific periods on
respiratory health and differential lung growth.
We thank all the families who took part in this study, the midwives for their
help in recruiting them, and the whole ALSPAC team, which includes
interviewers, computer and laboratory technicians, clerical workers, research
scientists, volunteers, managers, receptionists, and nurses.
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METHODS
Growth trajectories
Length and height data for the childrenwere available from several sources.
Birth length (crown-heel) was measured with a Harpenden Neonatometer
(Holtain, Crosswell, Crymych, UnitedKingdom) by trained research staff who
visited newborns soon after birth (median, 1 day; range, 1 to 14 days). From
birth to age 5 years, measurements were available from health visitor records,
which form part of standard childcare in the United Kingdom, for the majority
of the cohort. On average, up to 4measurements were taken at 2, 10, 21, and 48
months of age, which has been demonstrated previously to have good
accuracy.E1 For a random 10% of the cohort, direct measurements from a
series of research clinics held between the ages of 4 months and 5 years
were also available. At these clinics, crown-heel length for children aged
4 to 25 months was measured with a Harpenden Neonatometer (Holtain),
and from 25 months onward, standing height was measured with a Leicester
height measure (Seca, Hamburg, Germany). Weight was measured by using
a Seca scale. From age 7 years upward, all children were invited to annual
clinics, at which time standing height was measured (without shoes) to the
last complete millimeter by using the Harpenden stadiometer (Holtain), and
Tanita Body Fat Analyses (Model TBF 305) were used for weight
measurement. Across all ages, parent-reported child heights and weights
were also available from questionnaires. These measurements were
comparable with routinely collected child health record height and weight
REFERENCES
E1. Wignarajah D, Cock ML, Pinkerton KE, Harding R. Influence of intrauterine
growth restriction on airway development in fetal and postnatal sheep. Pediatr
Res 2002;51:681-8.
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data with no systematic bias.E1 Therefore all the above-described height and
weight measurements were used to generate growth trajectories for height
and weight from children with at least 2 observed measurements.
We used fractional polynomials to find the best-fitting average trajectory
and used this to derive approximate knot points for a linear spline model.E2
A separate model was created for female and male subjects. We simplified
the models with the aim of having the same knot points in female and male
subjects for both weight and height and having knot points at round ages in
months. Model fit with these models was not appreciably lower than in the
optimal model. The defined knot points are 3 months and 1, 3, and 7 years,
thereby creating the following growth rate trajectories: 0 to 3 months, 3
months to 1 year, 1 to 3 years, 3 to 7 years, and 7 to 10 years. Growth rates
are presented as changes in SD, which were generated by subtracting the
mean from the person-specific value and dividing by the SD.
Please note that the studyWeb site contains details of all the data, which are
available through a fully searchable data dictionary at the followingWeb page:
www.bris.ac.uk/alspac/researchers/data-access/data-dictionary.
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FIG E1. Flow chart of participants in the study.
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TABLE E1. Time points at which information on determinants
and outcomes were obtained
Age (y) Determinant Outcomes
1 Growth model
2 Growth model
3 Growth model
4 Growth model
5 Growth model
6 Growth model
7 Growth model
8 Growth model Asthma
Bronchial responsiveness (methacholine)
Spirometry
9 Growth model
10 Growth model
11
12
13
14 Asthma
15 Bronchial reversibility (salbutamol)
Spirometry
16
17 Asthma
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TABLE E2. Characteristics of included and excluded children
and their mothers
Maternal characteristics
Included
(n 5 9723)
Excluded
(n 5 4593)
P value
difference
Age (y)
<20 4.3 (404) 14.2 (592) <.001
20-24 19.8 (1873) 32.6 (1260)
41.8 (3945) 33.2 (1387)
30-34 26.1 (2466) 15.5 (646)
>_35 8.0 (756) 4.5 (188)
Missing 2.9 (279) 9.1 (420)
Body mass index (kg/m2)
<20 18.2 (1541) 22.1 (614) <.001
20-24 61.3 (5183) 56.8 (1581)
25-29 15.2 (1282) 15.0 (418)
>_30 5.3 (448) 6.1 (171)
Missing 13.1 (1269) 39.4 (1809)
Education (%)
Low/medium 60.3 (5454) 77.5 (2366) <.001
Higher 39.7 (3,596) 22.5 (686)
Missing 6.9 (673) 33.6 (1541)
History of asthma (%)
No 88.8 (8042) 88.2 (2718) .363
Yes 11.2 (1018) 11.8 (365)
Missing 6.8 (663) 32.9 (1510)
Anxiety during pregnancy
(%)
No 73.3 (6162) 66.4 (2033) <.001
Yes 26.7 (2241) 33.6 (1030)
Missing 13.6 (1220) 33.3 (1530)
Smoking during pregnancy
(%)
No 84.0 (7753) 70.4 (2535) <.001
Yes 16.0 (1472) 29.6 (1065)
Missing 5.1 (498) 21.6 (993)
Parity (%)
0 46.0 (4181) 42.1 (1479) <.001
>_1 54.0 (4909) 57.9 (2031)
Missing 6.5 (633) 29.6 (1083)
Child characteristics
Female sex (%) 49.5 (4814) 47.1 (2165) .008
Gestational age at birth
(wk)
40.0 (35.0-42.0) 40.0 (34.0-42.0) .006
Birth weight (g) 3438 (532) 3362 (556) <.001
Breast-feeding duration (%)
Never 23.3 (1999) 38.6 (759) <.001
<3 mo 22.9 (1972) 22.6 (465)
3-6 mo 17.1 (1472) 14.8 (305)
>_6 mo 36.8 (3163) 24.0 (494)
Missing 11.5 (1117) 55.2 (2534)
Values are means (SDs), medians (2.5th-97.5th percentiles), or percentages (absolute
numbers). Differences were tested by using the Student t test for continuous variables,
the x2 test for categorical variables, and the Mann-Whitney test for the not normally
distributed variable (gestational age at birth).
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TABLE E3. Growth (height and weight) with skin prick tests
OR (95% CI [n 5 6439]) P value
Height
Birth length (SD) 0.93 (0.84-1.02) .13
0-3 mo (SD/mo) 0.99 (0.92-1.06) .73
3-12 mo (SD/mo) 1.02 (0.92-1.13) .72
1-3 y (SD/mo) 0.96 (0.89-1.04) .35
3-7 y (SD/mo) 0.97 (0.86-1.10) .66
7-10 y (SD/mo) —
Weight
Birth weight (SD) 1.07 (0.96-1.19) .21
0-3 mo (SD/mo) 1.03 (0.96-1.11) .37
3-12 mo (SD/mo) 0.98 (0.91-1.06) .68
1-3 y (SD/mo) 1.08 (0.99-1.17) .08
3-7 y (SD/mo) 1.02 (0.93-1.11) .69
7-10 y (SD/mo) —
Values are ORs (95% CIs) for positive skin prick test responses. Models are adjusted
for maternal age, education level, history of asthma, body mass index, parity, smoking
during pregnancy, anxiety, and the child’s sex, gestational age, breast-feeding
duration, and previous height or weight gain. Models of weight were additionally
adjusted for preceding height and weight growth trajectories, and models of height
were additionally adjusted for preceding height growth trajectories and birth weight.
J ALLERGY CLIN IMMUNOL
JUNE 2015
1443.e5 SONNENSCHEIN-VAN DER VOORT ET AL
TABLE E4. Growth (height and weight) with lung function measures
Mean difference (95% CI)
Height growth Weight growth
8 y of age 15 y of age 8 y of age 15 y of age
FVC
Birth 20.002 (20.039 to 0.035) 20.142 (20.187 to 20.096) 0.081 (0.040 to 0.122) 0.058 (0.008 to 0.108)
0-3 mo 20.013 (20.042 to 0.016) 20.049 (20.084 to 20.014) 0.061 (0.034 to 0.088) 0.052 (0.019 to 0.085)
3-12 mo 20.004 (20.044 to 0.037) 20.052 (20.101 to 20.004) 0.065 (0.035 to 0.095) 0.058 (0.022 to 0.095)
1-3 y 20.006 (20.038 to 0.026) 20.047 (20.086 to 20.009) 0.085 (0.054 to 0.116) 0.073 (0.035 to 0.110)
3-7 y 20.009 (20.055 to 0.037) 0.001 (20.054 to 0.056) 0.114 (0.080 to 0.147) 0.124 (0.083 to 0.165)
7-10 y 20.031 (20.105 to 0.044) 0.102 (0.047 to 0.158)
FEV1
Birth 0.006 (20.032 to 0.043) 20.124 (20.171 to 20.078) 0.082 (0.041 to 0.124) 0.026 (20.025 to 0.077)
0-3 mo 20.011 (20.04 to 0.018) 20.055 (20.091 to 20.019) 20.014 (20.041 to 0.013) 0.039 (0.005 to 0.073)
3-12 mo 0.016 (20.025 to 0.056) 20.044 (20.093 to 0.006) 0.034 (0.004 to 0.064) 0.057 (0.019 to 0.094)
1-3 y 20.008 (20.040 to 0.024) 20.05 (20.090 to 20.011) 0.092 (0.06 to 0.123) 0.062 (0.024 to 0.101)
3-7 y 20.04 (20.086 to 0.007) 0.006 (20.050 to 0.063) 0.063 (0.029 to 0.096) 0.112 (0.070 to 0.154)
7-10 y 20.015 (20.092 to 0.062) 0.060 (0.002 to 0.118)
FEF25-75
Birth 20.003 (20.041 to 0.034) 20.029 (20.073 to 0.015) 20.014 (20.056 to 0.027) 20.072 (20.121 to 20.022)
0-3 mo 20.006 (20.034 to 0.023) 20.023 (20.057 to 0.011) 20.114 (20.142 to 20.087) 20.048 (20.081 to 20.015)
3-12 mo 0.014 (20.027 to 0.054) 20.021 (20.068 to 0.027) 20.052 (20.082 to 20.021) 20.031 (20.067 to 0.005)
1-3 y 20.005 (20.037 to 0.027) 20.022 (20.060 to 0.015) 0.008 (20.023 to 0.040) 20.007 (20.045 to 0.031)
3-7 y 20.055 (20.101 to 20.009) 0.016 (20.038 to 0.07) 20.088 (20.122 to 20.054) 0.004 (20.039 to 0.047)
7-10 y 0.026 (20.047 to 0.099) 20.058 (20.114 to 20.002)
FEV1/FVC ratio
Birth 0.015 (20.027 to 0.057) 0.051 (0.000328 to 0.101) 0.001 (20.040 to 0.042) 20.077 (20.122 to 20.031)
0-3 mo 0.007 (20.029 to 0.044) 20.032 (20.074 to 0.011) 20.129 (20.155 to 20.102) 20.041 (20.071 to 20.010)
3-12 mo 0.037 (20.008 to 0.082) 0.027 (20.025 to 0.080) 20.058 (20.088 to 20.028) 20.021 (20.054 to 0.013)
1-3 y 0.059 (0.008 to 0.109) 20.026 (20.086 to 0.034) 0.018 (20.014 to 0.049) 20.002 (20.037 to 0.033)
3-7 y 0.035 (20.087 to 0.157) 0.046 (20.099 to 0.191) 20.069 (20.103 to 20.035) 0.002 (20.038 to 0.041)
7-10 y 0.009 (20.075 to 0.093) 20.067 (20.119 to 20.016)
FEF25-75/FVC ratio
Birth 20.002 (20.043 to 0.04) 0.063 (0.016 to 0.109) 0.048 (0.007 to 0.088) 20.042 (20.09 to 0.007)
0-3 mo 0.021 (20.015 to 0.057) 20.031 (20.07 to 0.008) 20.11 (20.137 to 20.083) 20.002 (20.035 to 0.03)
3-12 mo 0.026 (20.019 to 0.070) 0.024 (20.025 to 0.072) 20.024 (20.054 to 0.005) 0.025 (20.01 to 0.061)
1-3 y 0.048 (20.002 to 0.098) 20.020 (20.075 to 0.035) 0.062 (0.031 to 0.094) 0.038 (0.002 to 0.075)
3-7 y 20.026 (20.147 to 0.095) 0.064 (20.07 to 0.198) 20.014 (20.047 to 0.02) 0.069 (0.029 to 0.109)
7-10 y 0.04 (20.038 to 0.118) 0.003 (20.052 to 0.058)
Values are differences in z score lung function (95% CIs). Z scores were calculated for sex, age, and height at the time of measurement. Models are adjusted for maternal age,
education level, body mass index, parity, smoking during pregnancy, anxiety, history of asthma, and the child’s sex, gestational age, and breast-feeding duration. Models of weight
were additionally adjusted for preceding height and weight growth trajectories, and models of height were additionally adjusted for preceding height growth trajectories and birth
weight. Models for lung function at 15 years of age were additionally adjusted for lung function measures at age 8 years.
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TABLE E5. Weight growth trajectories and lung function in strata of current body mass index
FVC (z score) P value
P value
for interaction FEV1 (z score) P value
P value
for interaction FEF25-75 (z score) P value
P value
for interaction
8 y of age
Normal BMI at 8 y
Birth weight (SD) 0.072 (0.020 to 0.124) .006 .85 0.062 (0.010 to 0.115) .02 .77 20.033 (20.086 to 0.019) .21 .99
0-3 mo (SD/mo) 0.056 (0.021 to 0.091) .001 .13 20.007 (20.041 to 0.028) .71 .03 20.103 (20.137 to 20.068) <.001 .25
3-12 mo (SD/mo) 0.062 (0.023 to 0.101) .002 .42 0.048 (0.008 to 0.087) .02 .02 20.024 (20.063 to 0.015) .23 .01
1-3 y (SD/mo) 0.086 (0.043 to 0.128) <.001 .38 0.089 (0.046 to 0.132) <.001 .52 0.007 (20.036 to 0.050) .76 .49
3-7 y (SD/mo) 0.293 (0.217 to 0.368) <.001 <.001 0.266 (0.190 to 0.343) <.001 <.001 20.084 (20.161 to 20.006) .03 .01
7-10 y (SD/mo)
Overweight at 8 y
Birth weight (SD) 0.087 (0.014 to 0.160) .02 .85 0.101 (0.027 to 0.175) .01 .77 0.024 (20.052 to 0.100) .53 .99
0-3 mo (SD/mo) 0.035 (20.014 to 0.083) .16 .13 20.025 (20.074 to 0.025) .33 .03 20.086 (20.137 to 20.035) .001 .25
3-12 mo (SD/mo) 0.039 (20.013 to 0.092) .14 .42 20.002 (20.055 to 0.051) .95 .02 20.080 (20.134 to 20.026) .004 .01
1-3 y (SD/mo) 0.061 (0.008 to 0.114) .03 .38 0.096 (0.043 to 0.150) .001 .52 0.051 (20.004 to 0.107) .07 .49
3-7 y (SD/mo) 0.049 (20.009 to 0.106) .10 <.001 20.010 (20.069 to 0.049) .733 <.001 20.091 (20.151 to 20.030) .003 .01
7-10 y (SD/mo)
15 y of age
Normal BMI at 15 y
Birth weight (SD) 0.076 (0.021 to 0.131) .007 .09 0.043 (20.015 to 0.101) .15 .22 20.080 (20.185 to 0.026) .14 .64
0-3 mo (SD/mo) 0.022 (20.015 to 0.059) .25 .06 0.017 (20.022 to 0.056) .39 .11 20.019 (20.056 to 0.019) .32 .08
3-12 mo (SD/mo) 0.037 (20.005 to 0.078) .08 .82 0.033 (20.010 to 0.077) .13 .85 0.016 (20.025 to 0.057) .45 .46
1-3 y (SD/mo) 0.055 (0.011 to 0.099) .01 .01 0.046 (0.000 to 0.093) .05 .22 0.035 (20.009 to 0.079) .12 .17
3-7 y (SD/mo) 0.192 (0.131 to 0.252) <.001 <.001 0.218 (0.154 to 0.281) <.001 <.001 0.178 (0.117 to 0.238) <.001 <.001
7-10 y (SD/mo) 0.110 (0.041 to 0.180) .002 <.001 0.072 (20.002 to 0.145) .06 <.001 20.008 (20.078 to 0.061) .81 <.001
Overweight at 15 y
Birth weight (SD) 20.036 (20.146 to 0.074) .52 .09 20.052 (20.161 to 0.057) .35 .22 20.032 (20.087 to 0.023) .26 .64
0-3 mo (SD/mo) 0.127 (0.055 to 0.200) .001 .06 0.098 (0.025 to 0.170) .008 .11 0.050 (20.021 to 0.121) .17 .08
3-12 mo (SD/mo) 0.055 (20.023 to 0.134) .17 .82 0.079 (0.001 to 0.156) .048 .85 0.036 (20.040 to 0.112) .35 .46
1-3 y (SD/mo) 0.047 (20.029 to 0.124) .23 .01 0.062 (20.014 to 0.138) .11 .22 0.034 (20.041 to 0.108) .37 .17
3-7 y (SD/mo) 20.057 (20.137 to 0.022) .16 <.001 20.041 (20.120 to 0.038) .31 <.001 20.051 (20.128 to 0.026) .19 <.001
7-10 y (SD/mo) 0.036 (20.070 to 0.143) .51 <.001 0.040 (20.064 to 0.145) .45 <.001 0.043 (20.060 to 0.146) .41 <.001
Values are differences in z score lung function (95% CIs). Z scores were calculated for sex, age, and height at the time of measurement. Models are adjusted for maternal age, education level, body mass index, parity, smoking during
pregnancy, anxiety, history of asthma, and the child’s sex, gestational age, and breast-feeding duration. Models of weight were additionally adjusted for preceding height and weight growth trajectories, and models of height were
additionally adjusted for preceding height growth trajectories and birth weight. Models for lung function at age 15 years were additionally adjusted for lung function measures at age 8 years.
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